Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease - Archive ouverte HAL Access content directly
Journal Articles American Journal of Clinical Medicine Research Year : 2013

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease

(1)
1
Narcisse Elenga
  • Function : Correspondent author
  • PersonId : 948268

Connectez-vous pour contacter l'auteur

Abstract

Patients with sickle cell disease frequently require red blood cell transfusions. However, transfusions can cause delayed hemolytic transfusion reaction (DHTR), a serious and potentially life-threatening complication of alloimmunization that results in hemolysis of transfused as well as patients' own red cells. Although we are beginning to understand some of the pathophysiology and risk factors associated with alloimmunization, optimal management of DHTR in this patient population is still under debate. Here, I will review the clinical features, pathophysiology, laboratory evaluation, current strategies for management and prevention of DHTRs. Given that DHTRs are associated with massive hemolysis, it is recommended that all patients with sickle cell disease receiving transfusions are carefully and systematically monitored after each transfusion.
Fichier principal
Vignette du fichier
ajcmr-1-3-2.pdf (116.04 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00922212 , version 1 (24-12-2013)

Identifiers

Cite

Narcisse Elenga. Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease. American Journal of Clinical Medicine Research, 2013, 1 (3), pp.40-44. ⟨10.12691/ajcmr-1-3-2⟩. ⟨inserm-00922212⟩

Collections

INSERM
303 View
352 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More